Browsing by Author Derdemezis, C. S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 2 to 20 of 20 < previous 
TitleAuthor(s)Issue date???itemlist.???
Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS AdipocytesDerdemezis, C. S.; Kiortsis, D. N.; Tsimihodimos, V.; Petraki, M. P.; Vezyraki, P.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemiaKostapanos, M. S.; Derdemezis, C. S.; Filippatos, T. D.; Milionis, H. J.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritisDerdemezis, C. S.; Filippatos, T. D.; Voulgari, P. V.; Tselepis, A. D.; Drosos, A. A.; Kiortsis, D. N.24-Nov-2015-
The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemiaNakou, E. S.; Filippatos, T. D.; Kiortsis, D. N.; Derdemezis, C. S.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot studyDerdemezis, C. S.; Filippatos, T. D.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effects of Fenofibrate and Orlistat, Alone or in Combination, on Plasma Visfatin Levels in Subjects with Metabolic SyndromeDerdemezis, C. S.; Filippatos, T. D.; Nakou, E. S.; Georgoula, M.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Effects of Orlistat and Fenofibrate, Alone or in Combination, on Plasma Apolipoprotein C-Ii and C-Iii Levels in Metabolic Syndrome PatientsFilippatos, T. D.; Kostapanos, M. S.; Kostara, C.; Nakou, E. S.; Georgoula, M.; Derdemezis, C. S.; Kiortsis, D. N.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Effects of Rimonabant, as Monotherapy and in Combination With Fenofibrate or Ezetimibe, on Plasma Adipokine Levels: A Pilot StudyFlorentin, M.; Liberopoulos, E. N.; Tellis, C. C.; Derdemezis, C. S.; Elisaf, M.; Tselepis, A.24-Nov-2015-
Effects of sibutramine plus verapamil SR/trandolapril combination on blood pressure and metabolic parameters in obese patients with mild hypertensionFilippatos, T. D.; Nakou, E.; Liberopoulos, E. N.; Derdemezis, C. S.; Georgoula, M.; Tselepis, A. D.; Elisaf, M. S.; Kiortsis, D. N.24-Nov-2015-
Excess body weight and risk of first-ever acute ischaemic non-embolic stroke in elderly subjectsMilionis, H. J.; Filippatos, T. D.; Derdemezis, C. S.; Kalantzi, K. J.; Goudevenos, J.; Seferiadis, K.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndromeFilippatos, T. D.; Derdemezis, C. S.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Increased plasma visfatin concentration is a marker of an atherogenic metabolic profileFilippatos, T. D.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Mikhailidis, D. P.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Increased plasma visfatin levels in subjects with the metabolic syndromeFilippatos, T. D.; Derdemezis, C. S.; Gazi, I. F.; Lagos, K.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Leptin and adiponectin levels in patients with ankylosing spondylitis. The effect of infliximab treatmentDerdemezis, C. S.; Filippatos, T. D.; Voulgari, P. V.; Tselepis, A. D.; Drosos, A. A.; Kiortsis, D. N.24-Nov-2015-
Obesity, adipose tissue and rheumatoid arthritis: coincidence or more complex relationship?Derdemezis, C. S.; Voulgari, P. V.; Drosos, A. A.; Kiortsis, D. N.24-Nov-2015-
Orlistat-associated adverse effects and drug interactions: a critical reviewFilippatos, T. D.; Derdemezis, C. S.; Gazi, I. F.; Nakou, E. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Plasma Visfatin Concentration Is a Marker of an Atherogenic Metabolic ProfileFilippatos, T.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Review article: effects of plant sterols and stanols beyond low-density lipoprotein cholesterol loweringDerdemezis, C. S.; Filippatos, T. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Visfatin/PBEF and atherosclerosis-related diseasesFilippatos, T. D.; Randeva, H. S.; Derdemezis, C. S.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-